Skip to main content

Table 1 Structural formula, GI50, and pGI50 of the data set

From: Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents

S/No.

Structural formula

GI50 (μM)

 

pGI50 (μM)

1n

C33H43ClN8O4S

0.023

 

7.6383

2

C28H34ClN7O6S2

0.04

 

7.398

3

C28H34ClN7O4S

0.043

 

7.3665

4

C29H36ClN7O4S

0.015

 

7.8239

5

C30H38ClN7O4S

0.025

 

7.6021

6

C30H38ClN7O5S

0.041

 

7.3872

7

C33H42ClN7O4S

0.077

 

7.1135

8 n

C27H31ClN6O5S

1.2

 

5.9208

9

C28H33ClN6O4S

0.24

 

6.6198

10

C32H41ClN8O3S

7.1

 

5.1487

11

C31H40ClN7O4S

0.3

 

6.5229

12

C34H46N8O4S

0.027

 

7.5686

13

C30H39N7O4S

0.043

 

7.3665

14

C29H37N7O4S

0.19

 

6.7212

15

C26H27ClF3N7O2

0.26

 

6.5850

16

C25H26Cl2FN7O2

0.1

 

7.0000

17

C25H26ClF2N7O2

0.13

 

6.8861

18

C24H28ClN7O2S

0.22

 

6.6576

19 n

C30H37ClN8O3

0.95

 

6.0223

20

C27H29ClF3N7O2

1.8

 

5.7447

21

C27H33ClN8O4S

0.031

 

7.5086

22

C28H35ClN7O3P

0.026

 

7.5850

23

C29H37ClN7O3P

0.22

 

6.6576

24

C26H30ClN6O4P

0.78

 

6.1079

25

C27H33ClN7O5PS

0.89

 

6.0506

26

C32H41ClN7O3P

0.041

 

7.3872

27

C27H31ClN8O3

0.05

 

7.3010

28 n

C29H35ClN8O3

0.079

 

7.1024

29

C28H31ClN8O4

0.25

 

6.6021

30

C32H40ClN9O3

0.21

 

6.6778

31

C27H29ClN8O2

0.44

 

6.3566

32

C28H31ClN8O2

0.43

 

6.3665

33

C25H24ClN7O3

1.2

 

5.9208

34 n

C31H36ClN9O2

0.2

 

6.6989

35

C29H38ClN7O4S

0.7

 

6.1549

  1. nTest set